At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative: FDA Safety Communication
FDA Infant Formula Update: August 10, 2022
FDA Infant Formula Update: August 10, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-august-10-2022
Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply
Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply
http://www.fda.gov/news-events/press-announcements/monkeypox-update-fda-authorizes-emergency-use-jynneos-vaccine-increase-vaccine-supply
FDA Roundup: August 9, 2022
FDA Roundup: August 9, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-9-2022
FDA Issues Warning Letters to Three Companies for Selling Unapproved New Drugs for Mole and Skin Tag Removal
FDA Issues Warning Letters to Three Companies for Selling Unapproved New Drugs for Mole and Skin Tag Removal
http://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-three-companies-selling-unapproved-new-drugs-mole-and-skin-tag-removal
Haimen Shengbang Laboratory Equipment Co. Ltd. Recalls Viral Transport Media Containers That Are Not Authorized, Cleared, or Approved by the FDA
FDA Roundup: August 5, 2022
FDA Roundup: August 5, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-august-5-2022
FDA Infant Formula Update: August 5, 2022
FDA Infant Formula Update: August 5, 2022
http://www.fda.gov/news-events/press-announcements/fda-infant-formula-update-august-5-2022
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer
FDA Approves First Targeted Therapy for HER2-Low Breast Cancer
http://www.fda.gov/news-events/press-announcements/fda-approves-first-targeted-therapy-her2-low-breast-cancer